Hot Topics IV

Emmanuel J. Favaloro

doi:10.1055/s-0032-1333463

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2013; 39(01): 001-004
DOI: 10.1055/s-0032-1333463

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hot Topics IV

Emmanuel J. Favaloro

¹Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, Australia

› Author Affiliations

Abstract

Full Text

References

References
1 Favaloro EJ. Hot Topics I: a potpourri of current issues and controversies in Thrombosis and hemostasis. Semin Thromb Hemost 2007; 33 (8) 723-726
2 Favaloro EJ. Hot topics II: an editorial collection of current issues and controversies in thrombosis and hemostasis. Semin Thromb Hemost 2008; 34 (1) 3-6
3 Favaloro EJ. Hot topics III. Preface. Semin Thromb Hemost 2012; 38 (1) 1-4
4 Favaloro EJ. Editorial. Winners of the Inaugural Eberhard F. Mammen award for most popular article. Semin Thromb Hemost 2009; 35: 587-590
5 Favaloro EJ. Winners of the 2010 Eberhard F. Mammen award for most popular article during 2008-2009. Semin Thromb Hemost 2010; 36 (7) 685-692
6 Favaloro EJ. 2012 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2012; 38 (5) 425-432
7 Bernard TJ, Armstrong-Wells J, Goldenberg NA. The institution-based prospective inception cohort study: design, implementation, and quality assurance in pediatric thrombosis and stroke research. Semin Thromb Hemost 2013; 39 (1) 10-14
8 Italiano J. Unraveling mechanisms that control platelet production. Semin Thromb Hemost 2013; 39 (1) 15-24
9 McEwen BJ, Morel-Kopp M-C, Chen W, Tofler GH, Ward CM. Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease. Semin Thromb Hemost 2013; 39 (1) 25-32
10 Lacroix R, Dignat-George F. Microparticles: new protagonists in pericellular and intravascular proteolysis. Semin Thromb Hemost 2013; 39 (1) 33-39
11 Chen VMY. Tissue factor de-encryption, thrombus formation, and thiol-disulfide exchange. Semin Thromb Hemost 2013; 39 (1) 40-47
12 Lippi G, Mattiuzzi C, Favaloro EJ. Novel and emerging therapies: thrombus-targeted fibrinolysis. Semin Thromb Hemost 2013; 39 (1) 48-58
13 Lippi G, Franchini M, Favaloro EJ, Targher G. Moderate red wine consumption and cardiovascular disease risk: beyond the “French paradox”. Semin Thromb Hemost 2010; 36 (1) 59-70
14 Gobbi G, Mirandola P, Carubbi C, Galli D, Vitale M. Protein kinase C ε in hematopoiesis: conductor or selector?. Semin Thromb Hemost 2013; 39 (1) 59-65
15 Harenberg J, Du S, Krämer S , et al. Novel methods for assessing oral direct factor Xa and thrombin inhibitors: use of point-of-care testing and urine samples. Semin Thromb Hemost 2013; 39 (1) 66-71
16 Dentali F, Sironi AP, Ageno W , et al. Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis. Semin Thromb Hemost 2013; 39 (1) 72-82
17 Lippi G, Favaloro EJ, Cervellin G. Massive posttraumatic bleeding: epidemiology, causes, clinical features, and therapeutic management. Semin Thromb Hemost 2013; 39 (1) 83-93
18 Franchini M, Frattini F, Crestani S, Bonfanti C. Bleeding complications in patients with hematological malignancies. Semin Thromb Hemost 2013; 39 (1) 94-100
19 McMahon B, Stein BL. Thrombotic and bleeding complications in classical myeloproliferative neoplasms. Semin Thromb Hemost 2013; 39 (1) 101-111